Table 1.
Case No. | Reference | Age | Sex | Primary location | Primary stage | CEA | FDG-PET | Time after primary resection (months) | Treatment | Follow-up period (months) | Recurrence |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Kuba et al. [4] | 60 | F | sigmoid | IIIB | elevated | NL | 33 | resection | NL | NL |
2 | Iwata et al. [5] | 75 | M | ascending | IIIA | elevated | uptake | 42 | resection | 13 | none |
3 | Musallam et al. [6] | 67 | M | rectum | IIIB | normal | uptake | 26 | NL | NL | NL |
4 | Matsuda et al. [7] | 65 | M | sigmoid | IIIB | normal | uptake | 101 | resection | 72 | none |
5 | Matsuda et al. [7] | 50 | M | rectum | IIIB | elevated | uptake | 96 | resection | 4 | none |
6 | Shirakawa et al. [8] | 65 | M | rectum | IIIA | elevated | uptake | 55 | resection | NL | NL |
7 | Our case, 2016 | 59 | M | ascending | IIIB | normal | uptake | 32 | resection | 20 | none |
CEA: carcinoembryonic antigen.
FDG-PET: 18F-fluorodeoxyglucose positron emission tomography.
NL: not listed.